It has been about a month since the last earnings report for GSK (GSK). Shares have added about 8% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up ...

The stock of GlaxoSmithKline Pharmaceuticals (GSK Pharma) hit a three-month high of ₹2,640 a share as it surged 5 per cent on Monday before closing at ₹2,638. During the past seven trading days, the ...

In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other pharmaceutical stocks. Almost no other industry goes as far as the phrase "defensive" as the ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. UK drugmaker GSK is struggling to convince the market that it can deliver on its plans to refill its ...

GSK’s MenABCWY vaccine application was supported by the results from two Phase III trials. Credit: MAXSHOT.PL/Shutterstock. GSK has secured approval from the US Food and Drug Administration (FDA) for ...

GSK plc GSK reported fourth-quarter 2024 core earnings of 59 cents per American depositary share (ADS), which beat the Zacks Consensus Estimate of 53 cents. Core earnings declined 20% year over ...

Our congratulations go to the 10 charities that have won a 2024 GSK IMPACT Award for their outstanding contributions to improving the UK’s health and wellbeing. We are delighted to announce Ivison ...

The 2026 GSK IMPACT Awards will open for applications in July 2025. If you would like to receive details please complete the enquiries form at the bottom of this page. The GSK IMPACT Awards are open ...

Increasing evidence suggests that elevated activity of glycogen synthesis kinase-3β (GSK-3β) contributes to the pathogenesis of PD (Golpich et al., 2015). Expression of GSK-3β was found to be ...